These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21192146)

  • 1. Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors.
    Gillman PK
    J Clin Psychopharmacol; 2011 Feb; 31(1):66-74. PubMed ID: 21192146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.
    Polasek TM; Elliot DJ; Somogyi AA; Gillam EM; Lewis BC; Miners JO
    Br J Clin Pharmacol; 2006 May; 61(5):570-84. PubMed ID: 16669850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.
    Salsali M; Holt A; Baker GB
    Cell Mol Neurobiol; 2004 Feb; 24(1):63-76. PubMed ID: 15049511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranylcypromine in mind (Part I): Review of pharmacology.
    Ulrich S; Ricken R; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines.
    GEY KF; PLETSCHER A; BURKARD W
    Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase.
    Teychenne PF; Calne DB; Lewis PJ; Findley LJ
    Clin Pharmacol Ther; 1975 Sep; 18(3):273-7. PubMed ID: 1164817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.
    HORWITZ D; LOVENBERG W; ENGELMAN K; SJOERDSMA A
    JAMA; 1964 Jun; 188():1108-10. PubMed ID: 14163106
    [No Abstract]   [Full Text] [Related]  

  • 8. MONOAMINE-OXIDASE INHIBITOR REACTIONS SIMULATING PHENOCHROMOCYTOMA ATTACKS.
    PLASS HF
    Ann Intern Med; 1964 Nov; 61():924-7. PubMed ID: 14233813
    [No Abstract]   [Full Text] [Related]  

  • 9. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
    Baker GB; Coutts RT; McKenna KF; Sherry-McKenna RL
    J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of monoamine oxidase inhibitors.
    Baker GB; Coutts RT
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):395-403. PubMed ID: 2664891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.
    Van den Eynde V; Gillman PK; Blackwell BB
    Psychopharmacol Bull; 2022 May; 52(2):73-116. PubMed ID: 35721816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MONOAMINE OXIDASE INHIBITORS: AUGMENTATION OF PRESSOR EFFECTS OF PERORAL TYRAMINE.
    TEDESCHI DH; FELLOWS EJ
    Science; 1964 Jun; 144(3623):1225-6. PubMed ID: 14150325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TYRAMINE IN CHEESE RELATED TO HYPERTENSIVE CRISES AFTER MONOAMINE-OXIDASE INHIBITION.
    BLACKWELL B; MABBITT LA
    Lancet; 1965 May; 1(7392):938-40. PubMed ID: 14275713
    [No Abstract]   [Full Text] [Related]  

  • 14. The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.
    Van den Eynde V
    J Neural Transm (Vienna); 2021 Nov; 128(11):1741-1756. PubMed ID: 34373944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
    Baker GB; Sowa B; Todd KG
    J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
    [No Abstract]   [Full Text] [Related]  

  • 16. INTERACTION BETWEEN CHEESE AND MONOAMINE-OXIDASE INHIBITORS IN RATS AND CATS.
    BLACKWELL B; MARLEY E
    Lancet; 1964 Mar; 1(7332):530-1. PubMed ID: 14100188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do monoamine oxidase inhibitors alter carbamazepine blood levels?
    Barklage NE; Jefferson JW; Margolis D
    J Clin Psychiatry; 1992 Jul; 53(7):258. PubMed ID: 1639748
    [No Abstract]   [Full Text] [Related]  

  • 20. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.